Durvalumab User Reviews & Ratings
Brand names: Imfinzi
Durvalumab has an average rating of 7.5 out of 10 from a total of 8 reviews on Drugs.com. 63% of reviewers reported a positive experience, while 0% reported a negative experience.
| Condition | Avg. Rating | Reviews | Compare |
|---|---|---|---|
| Non Small Cell Lung Cancer | 5 reviews for Non Small Cell Lung Cancer | 69 medications | |
| Small Cell Lung Cancer | 2 reviews for Small Cell Lung Cancer | 11 medications | |
| Hepatocellular Carcinoma | 1 reviews for Hepatocellular Carcinoma | 13 medications |
- Too...
- Taken for 1 to 6 months
- August 9, 2024
Durvalumab for Hepatocellular Carcinoma "Have had two infusions, and so far, so good—no side effects except feeling tired on the second day after infusion. Other than that one day, I feel fine. I have my next MRI in October to check for more cancer. Hopefully, Imfinzi is working, and I will have no return spots. Time will tell."
- jkp...
- Taken for 6 months to 1 year
- August 15, 2024
Durvalumab for Non Small Cell Lung Cancer "Cancer in remission just before 10th treatment. Many skin problems. Dry, cracking skin on sides and bottom of feet. Dry skin on arms and legs. Occasional mild headaches, terrible problems sleeping at night. All problems on mild side."
Frequently asked questions
- Ger...
- Taken for 1 to 2 years
- August 15, 2024
Durvalumab for Small Cell Lung Cancer "3 to 4 days after I have a tightness in my chest, it does go away, I also have a rash on both arms. I have constipation. Now I am having trouble swallowing, the only thing I can swallow without difficulty is soft foods and liquids. I have to go and get an X-ray of my esophagus in September. Good news is the tumor continues to shrink. I just had a CT scan with contrast a couple of weeks ago. I do have to have a CT scan every 3 months. I believe Imfinzi is helping me."
- Ger...
- Taken for 6 months to 1 year
- November 4, 2024
Durvalumab for Small Cell Lung Cancer "I started Imfinzi in April 2024. My white blood count has increased over the last 4 months. My oncologist has done at least 3 CT scans, nothing has changed on the scans. The tumor has shrunk. I also have really bad pain in my upper back, which is on the side where the cancer is. The oncologist has no answers. Also, my thyroid level is very high, I am taking medication for that. Doesn't seem to be helping, though."
- Dur...
- Taken for 1 to 2 years
- October 17, 2023
For Non Small Cell Lung Cancer "During immunotherapy treatment for one year, I developed constipation, horrible itching all over my body with no relief from creams or any other treatments. Also, it shrunk my thyroid gland, so that I will have to stay on thyroid medicine for the rest of my life. I hope it worked on the cancer. We shall see."
- Ano...
- Taken for 6 months to 1 year
- June 2, 2025
Durvalumab for Non Small Cell Lung Cancer "I am on my 11th month of Imfinzi, it has given me tachycardia, as well as weakness and fatigue the longer I have been on it. Also, I have not noticed any reduction in my tumor in 8 months, as well as it spread back into the lymph nodes."
- Anonymous
- Taken for 6 months to 1 year
- April 1, 2024
Durvalumab for Non Small Cell Lung Cancer "Had 12 treatments after completion of chemoradiation. Medication was well tolerated with minimal side effects."
See also:
More about durvalumab
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
Durvalumab for Non Small Cell Lung Cancer "Also using to treat myeloma. Started taking late 2016. Seems to keep both cancers at bay. I have had some very strange lung infections. Not sure if related to treatment. My hair is very dry, thin, limp. Dry skin. Frequent urination. Fatigue. Restless nights. Depression. Body aches. I’m a 60-year-old male."